Winch Advisory Services LLC Sells 40,378 Shares of iShares Nasdaq Biotechnology ETF (IBB)

Winch Advisory Services LLC cut its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 94.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,224 shares of the financial services provider’s stock after selling 40,378 shares during the quarter. Winch Advisory Services LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $214,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in IBB. Lockheed Martin Investment Management Co. lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 173.9% in the 4th quarter. Lockheed Martin Investment Management Co. now owns 417,400 shares of the financial services provider’s stock valued at $40,250,000 after purchasing an additional 265,000 shares during the period. Credit Suisse AG lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 1,228.8% in the 3rd quarter. Credit Suisse AG now owns 224,782 shares of the financial services provider’s stock valued at $27,410,000 after purchasing an additional 207,866 shares during the period. Alliancebernstein L.P. lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 36.2% in the 3rd quarter. Alliancebernstein L.P. now owns 737,179 shares of the financial services provider’s stock valued at $89,892,000 after purchasing an additional 195,746 shares during the period. Morgan Stanley lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 3.7% in the 3rd quarter. Morgan Stanley now owns 4,026,110 shares of the financial services provider’s stock valued at $490,944,000 after purchasing an additional 143,209 shares during the period. Finally, Aviance Capital Management LLC lifted its stake in shares of iShares Nasdaq Biotechnology ETF by 730.2% in the 3rd quarter. Aviance Capital Management LLC now owns 147,849 shares of the financial services provider’s stock valued at $18,029,000 after purchasing an additional 130,040 shares during the period. 66.51% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:IBB traded up $0.23 during midday trading on Monday, reaching $108.03. The company’s stock had a trading volume of 88,840 shares, compared to its average volume of 2,008,017. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $89.01 and a fifty-two week high of $122.97.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://dakotafinancialnews.com/2019/02/11/winch-advisory-services-llc-sells-40378-shares-of-ishares-nasdaq-biotechnology-etf-ibb.html.



About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: What is the float in trading stocks?

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply